(1S,2S)-(+)-N,N-Dimethylcyclohexane-1,2-diamine
(1S,2S)-(+)-N,N-二甲基环己二胺
Application
Aleniglipron
CAS No. 894493-95-9
C₈H₁₈N₂
Therapeutic Area
37 intermediates
Area Overview
Driven by the catalog’s GLP-1, incretin, SGLT2 and DPP-4 programs, this area brings together intermediates for established diabetes therapies and emerging oral or peptide-based approaches to obesity and metabolic disease.
Classification is based on terminal APIs in the product catalog; product counts update with the catalog.
Representative Terminal APIs
37 catalog intermediates
(1S,2S)-(+)-N,N-二甲基环己二胺
Application
Aleniglipron
CAS No. 894493-95-9
C₈H₁₈N₂
1-((1S,2S)-2-甲基-1-(5-氧代-4,5-二氢-1,2,4-恶二唑-3-基)环丙基)-5-(四氢-2H-吡喃-4-基)-1H-吲哚-2-甲酸
Application
Aleniglipron
CAS No. 2212021-51-5
C₂₀H₂₁N₃O₅
叔丁基(S)-3-(3-(4-(二乙基磷酰基)-3-(甲基氨基)苯基)-2-氧代-2,3-二氢-1H-咪唑-1-基)-2-(4-氟-3,5-二甲基苯基)-4-甲基-2,4,6,7-四氢-5H-吡唑并[4,3-c]吡啶-5-甲酸酯
Application
Aleniglipron
CAS No. 2685825-07-2
C₃₄H₄₄FN₆O₄P
(R)-3-氨基哌啶二盐酸盐
Application
Alogliptin/Linagliptin
CAS No. 334618-23-4
C₅H₁₄Cl₂N₂
卡格列肽
Application
Cagrilintide
CAS No. 1415456-99-3
C₁₉₄H₃₁₂N₅₄O₅₉S₂
2,3,4,6-四-O-三甲基硅基-D-葡萄糖酸内酯
Application
Canagliflozin/Dapagliflozin
CAS No. 32384-65-9
C₁₈H₄₂O₆Si₄
达格列酮
Application
Danuglipron
CAS No. 2230198-02-2
C₃₁H₃₀FN₅O₄
(3S)-3-[4-[(2-氯-5-碘苯基)甲基]苯氧基]四氢呋喃
Application
Empagliflozin
CAS No. 915095-94-2
C₁₇H₁₆ClIO₂
(5-溴-2-氯苯基)(4-羟基苯基)甲酮
Application
Empagliflozin
CAS No. 1360568-68-8
C₁₃H₈BrClO₂
(R)-3-(对甲苯磺酰氧基)四氢呋喃
Application
Empagliflozin
CAS No. 219823-47-9
C₁₁H₁₄O₄S
4-(5-溴-2-氯苄基)苯酚
Application
Empagliflozin
CAS No. 864070-18-8
C₁₃H₁₀BrClO
乙酰氧基恩格列净
Application
Empagliflozin
CAS No. 915095-99-7
C₃₁H₃₅ClO₁₁
芴甲氧羰基-赖氨酸(棕榈酰-谷氨酸-叔丁酯)-OH
Application
Liraglutide
CAS No. 1491158-62-3
C₄₆H₆₉N₃O₈
N-(1-氧代十六烷基)-L-谷氨酸叔丁酯
Application
Liraglutide
CAS No. 536721-25-2
C₂₅H₄₇NO₅
N-琥珀酰亚胺棕榈酸酯
Application
Liraglutide
CAS No. 14464-31-4
C₂₀H₃₅NO₄
棕榈酰-谷氨酸(OSu)-OH
Application
Liraglutide
CAS No. 294855-91-7
C₂₅H₄₂N₂O₇
棕榈酰-谷氨酸(OSu)-叔丁酯
Application
Liraglutide
CAS No. 204521-63-1
C₂₉H₅₀N₂O₇
玛仕度肽
Application
Mazdutide
CAS No. 2259884-03-0
C₂₀₇H₃₁₇N₄₅O₆₅
奥格列龙
Application
Orforglipron
CAS No. 2212020-52-3
C₄₈H₄₈F₂N₁₀O₅
瑞他鲁肽
Application
Retatrutide
CAS No. 2381089-83-2
Fmoc-L-赖氨酸[辛基(叔丁酯)-谷氨酸(叔丁酯)-AEEA-AEEA]-OSu
Application
Semaglutide
CAS No. 1118767-15-9
C₄₇H₈₂N₄O₁₅
(S)-22-(叔丁氧羰基)-10,19,24-三氧代-3,6,12,15-四氧杂-9,18,23-三氮杂四十一烷-1,41-二酸
Application
Semaglutide
CAS No. 1118767-16-0
C₄₃H₇₉N₃O₁₃
10-氧代-5,8,14,17-四氧杂-2,11-二氮杂十九烷二酸 1-(9H-芴-9-基甲基)酯
Application
Semaglutide
CAS No. 560088-89-3
C₂₇H₃₄N₂O₉
18-叔丁氧基-18-氧代十八烷酸
Application
Semaglutide
CAS No. 843666-40-0
C₂₂H₄₂O₄
Fmoc-8-氨基-3,6-二氧杂辛酸
Application
Semaglutide
CAS No. 166108-71-0
C₂₁H₂₃NO₆
Fmoc-L-赖氨酸[辛基(叔丁酯)-谷氨酸(叔丁酯)-AEEA-AEEA]-OH
Application
Semaglutide
CAS No. 1662688-20-1
C₆₄H₁₀₁N₅O₁₆
2,4,5-三氟苯乙酸
Application
Sitagliptin
CAS No. 209995-38-0
C₈H₅F₃O₂
3-(三氟甲基)-5,6,7,8-四氢-[1,2,4]三唑并[4,3-a]吡嗪盐酸盐
Application
Sitagliptin
CAS No. 762240-92-6
C₆H₈ClF₃N₄
BOC-(R)-3-氨基-4-(2,4,5-三氟苯基)丁酸
Application
Sitagliptin
CAS No. 486460-00-8
C₁₅H₁₈F₃NO₄
西他列汀碱
Application
Sitagliptin
CAS No. 486460-32-6
C₁₆H₁₅F₆N₅O
西他列汀磷酸盐一水合物
Application
Sitagliptin
CAS No. 654671-77-9
C₁₆H₂₀F₆N₅O₆P
苏沃度肽
Application
Survodutide
CAS No. 2805997-46-8
C₁₉₂H₂₈₉N₄₇O₆₁
替尔泊肽
Application
Tirzepatide
CAS No. 2023788-19-2
C₂₂₅H₃₄₈N₄₈O₆₈
L-脯氨酰胺
Application
Vildagliptin
CAS No. 7531-52-4
C₅H₁₀N₂O
5-[(S)-2,2-二甲基四氢-2H-吡喃-4-基]-1-[(1S,2S)-2-甲基-1-(5-氧代-4,5-二氢-1,2,4-噁二唑-3-基)环丙基]-1H-吲哚-2-甲酸
Application
Omarigliptin
CAS No. 2212021-83-3
C₂₂H₂₅N₃O₅
(S)-3-氨基-2-(4-氟-3,5-二甲基苯基)-4-甲基-2,4,6,7-四氢-5H-吡唑并[4,3-C]吡啶-5-羧酸叔丁酯
Application
Omarigliptin
CAS No. 2212021-59-3
C₂₀H₂₇FN₄O₂
(S)-2-(4-氟-3,5-二甲基苯基)-4-甲基-3-(2-氧代-2,3-二氢-1H-咪唑-1-基)-2,4,6,7-四氢-5H-吡唑并[4,3-C]吡啶-5-羧酸叔丁酯
Application
Omarigliptin
CAS No. 2212021-61-7
C₂₃H₂₈FN₅O₃
Need intermediates for this therapeutic area?
Ready to source? Our team responds to every inquiry within 24 hours.